SAN DIEGO, Feb. 11 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that Carl W. Hull has been named the Company's president and chief operating officer, effective March 1, 2008.
Mr. Hull, 50, joined Gen-Probe in February of 2007 as executive vice president and chief operating officer. He oversees the Company's major operating functions, including research and development, manufacturing, and sales and marketing.
"Carl's extensive industry experience and knowledge have been an asset to Gen-Probe over the last year," said Henry L. Nordhoff, Gen-Probe's chairman and chief executive officer. "His promotion reflects his contributions to date and the board's confidence in his future leadership."
Mr. Hull, a 26-year veteran of the diagnostics and life sciences industries, joined Gen-Probe from Applied Biosystems, where he was vice president and general manager of the Sequence Detection System and Microarrays business unit, which sells genomic testing systems and reagents. Before joining Applied Biosystems in 2005, Mr. Hull was chief executive officer of Applied Imaging Corporation. Prior to joining Applied Imaging in 1997, he held a variety of marketing and sales management positions at Ventana Medical Systems and Abbott Laboratories, both in the United States and internationally.
Mr. Hull earned a BA in political science and international relations from The Johns Hopkins University and an MBA from the University of Chicago.
Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations, beliefs,
plans, objectives, assumptions or future events or performance are not
historical facts and are forward-looking statements. These statements are
often, but not always, made through the use of words or phrases such as
believe, will, expect, anticipate, estimate, intend, plan and would. For
example, statements concerning plans and objectives of management are
forward-looking statements. Forward-looking statements are not guarantees
of performance. They involve known and unknown risks, uncertainties and
assumptions that may cause actual results, levels of activity, performance
or achievements to differ materially from those expressed or implied. Some
of these risks, uncertainties and assumptions include, but are not limited
to, the risk that management may not be successful in implementing its
business plans, and the risk that the Company may not be able to retain its
top executives or attract new ones. The foregoing sets forth some, but not
all, of the factors that could affect our ability to achieve results
described in any forward-looking statements. For additional information
about risks and uncertainties we face and a discussion of our financial
statements and footnotes, see documents we file with the SEC, including our
most recent annual report on Form 10-K and all subsequent periodic reports.
We assume no obligation and expressly disclaim any duty to update
forward-looking statements to reflect events or circumstances after the
date of this news release or to reflect the occurrence of subsequent
Senior director, investor relations and
|SOURCE Gen-Probe Incorporated|
Copyright©2008 PR Newswire.
All rights reserved